Bengt E. Karlberg

6.3k total citations · 3 hit papers
76 papers, 4.7k citations indexed

About

Bengt E. Karlberg is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Bengt E. Karlberg has authored 76 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Cardiology and Cardiovascular Medicine and 12 papers in Molecular Biology. Recurrent topics in Bengt E. Karlberg's work include Hormonal Regulation and Hypertension (29 papers), Blood Pressure and Hypertension Studies (24 papers) and Renin-Angiotensin System Studies (18 papers). Bengt E. Karlberg is often cited by papers focused on Hormonal Regulation and Hypertension (29 papers), Blood Pressure and Hypertension Studies (24 papers) and Renin-Angiotensin System Studies (18 papers). Bengt E. Karlberg collaborates with scholars based in Sweden, Finland and United States. Bengt E. Karlberg's co-authors include Jan Lanke, Thomas Hedner, Ulf dé Fairé, Lars Lindholm, Lennart Hansson, K Luomanmäki, Leo Niskanen, Anders Niklason, Claes Mörlin and Björn Dahlöf and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Bengt E. Karlberg

73 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1999 1.5k citations Lennart Hansson, Lars Lindholm et al. The Lancet profile →
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

2000 650 citations Lennart Hansson, Thomas Hedner et al. The Lancet profile →
Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

2004 625 citations Anthony Barnett, Stephen C. Bain et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Bengt E. Karlberg

Since Specialization

Citations

This map shows the geographic impact of Bengt E. Karlberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt E. Karlberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt E. Karlberg more than expected).

Fields of papers citing papers by Bengt E. Karlberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt E. Karlberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt E. Karlberg. The network helps show where Bengt E. Karlberg may publish in the future.

Co-authorship network of co-authors of Bengt E. Karlberg

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt E. Karlberg. A scholar is included among the top collaborators of Bengt E. Karlberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt E. Karlberg. Bengt E. Karlberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy breakdown → 2004 ·New England Journal of Medicine ·Anthony Barnett, Stephen C. Bain, (unknown), Bengt E. Karlberg, Sten Madsbad, J Jervell, Jukka Mustonen	625
2	Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study 2002 ·Journal of Hypertension ·Sverre E. Kjeldsen, Thomas Hedner, Jan Otto Syvertsen, Per Lund‐Johansen, Lennart Hansson, Jan Lanke, Lars Lindholm, Ulf dé Fairé, Björn Dahlöf, Bengt E. Karlberg	24
3	Long-term Exposure to Telmisartan as Monotherapy or Combination Therapy: Efficacy and Safety 2002 ·Blood Pressure ·(unknown), (unknown), Bengt E. Karlberg, Thomas Meinicke, Helmut Schumacher	21
4	Efficacy and Safety of a New Long-acting Drug Combination, Trandolapril/Verapamil as Compared to Monotherapy in Primary Hypertension 2000 ·Blood Pressure ·Bengt E. Karlberg	21
5	Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study breakdown → 2000 ·The Lancet ·Lennart Hansson, Thomas Hedner, Per Lund‐Johansen, Sverre E. Kjeldsen, Lars Lindholm, Jan Otto Syvertsen, Jan Lanke, Ulf dé Fairé, Björn Dahlöf, Bengt E. Karlberg	650
6	Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial breakdown → 1999 ·The Lancet ·Lennart Hansson, Lars Lindholm, Leo Niskanen, Jan Lanke, Thomas Hedner, Anders Niklason, K Luomanmäki, Björn Dahlöf, Ulf dé Fairé, Claes Mörlin, Bengt E. Karlberg, (unknown), (unknown)	1480
7	Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension 1999 ·Journal of Hypertension ·Bengt E. Karlberg, Lars‐Eric Lins, Karin Hermansson	90
8	Salivary Cortisol - an Alternative to Serum Cortisol Determinations in Dynamic Function Tests 1998 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Bengt E. Karlberg, Ann-Charlottè Holm	101
9	Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs 1997 ·American Journal of Veterinary Research ·Jens Häggström, Kerstin Hansson, Clarence Kvart, Bengt E. Karlberg, Olli Vuolteenaho, Kerstin Olsson	60
10	A Population Study of Plasma Neuropeptide Y: Correlations with Components of the Metabolic Syndrome 1996 ·Blood Pressure ·Fredrik H. Nyström, Peter M. Nilsson, Anders Olsson, Bengt E. Karlberg, K. Peter Öhman	13
11	Delivery and Retention of an Insulin Aerosol Produced by a New Jet Nebulizer 1995 ·Journal of Aerosol Medicine ·Johan Jendle, Bengt E. Karlberg, (unknown), Lennart Franzén, Måns Arborelius	8
12	Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels 1994 ·American Journal of Veterinary Research ·Jens Häggström, Kerstin Hansson, Bengt E. Karlberg, Clarence Kvart, Kerstin Olsson	86
13	Antiatherosclerotic Effects of the Angiotensin-Converting Enzyme Inhibitors Captopril and Fosinopril in Hypercholesterolemic Minipigs 1994 ·Journal of Cardiovascular Pharmacology ·(unknown), Karin Persson Waller, Gunnar Åberg, Rolf G. G. Andersson, Bengt E. Karlberg, Anders Olsson	43
14	Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus 1994 ·New England Journal of Medicine ·Mats Bojestig, Hans J. Arnqvist, Göran Hermansson, Bengt E. Karlberg, Johnny Ludvigsson	327
15	Acute and Steady‐State Pharmacokinetics and Antihypertensive Effects of Felodipine in Patients with Normal and Impaired Renal Function 1990 ·The Journal of Clinical Pharmacology ·Rutger Larsson, Bengt E. Karlberg, (unknown), (unknown), Carl‐Gunnar Regårdh	16
16	Increased Bronchial Reactivity and Potentiated Skin Responses in Hypertensive Subjects Suffering from Coughs during ACE-inhibitor Therapy 1989 ·CHEST Journal ·Björn Lindgren, Ulf Rosenqvist, Tommy Ekström, R. Grönneberg, Bengt E. Karlberg, Rolf G. G. Andersson	20
17	The value of the clonidine‐suppression test in the diagnosis of pheochromocytoma 1986 ·World Journal of Surgery ·Bengt E. Karlberg, (unknown), Sten Lennquist, Thomas Pollare	9
18	Long‐term Effects of Captopril and Atenolol in Essential Hypertension 1985 ·Acta Medica Scandinavica ·Lennart Andrén, Bengt E. Karlberg, Anders Svensson, Peter Öhman, Ove Nilsson, Lennart Hansson	10
19	Thyroid hormones and the adrenergic nervous system 1983 ·Acta Medica Scandinavica ·Ove Nilsson, Bengt E. Karlberg	20
20	EFFECTS OF SYNTHETIC TRH ON SERUM LEVELS OF HTSH, CORTISOL, STH, INSULIN AND PBI IN NORMAL SUBJECTS AND PATIENTS WITH PITUITARY AND THYROID DISORDERS 1971 ·European Journal of Endocrinology ·Bengt E. Karlberg, Sven Almqvist, Sigbritt Werner	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact